Clearpoint Neuro
Yahoo Finance • last year
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
SOLANA BEACH, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will releas... Full story
Yahoo Finance • last year
ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management... Full story
Yahoo Finance • last year
ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it will present inve... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will relea... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model
SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive world... Full story
Yahoo Finance • 2 years ago
A ClearPoint Neuro Anuncia Aprovação da Carteira de Navegação Neuro pela ANVISA no Brasil
SOLANA BEACH, Califórnia, April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (a "Empresa"), uma empresa de plataforma global que fornece navegação e entrega ao cérebro, anunciou hoje o registo bem sucedido da sua ca... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced successful registr... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS
SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced further expansion... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro annonce un accord de licence exclusif pluriannuel avec l'UCSF concernant une plateforme innovante pour l'administration cellulaire intracérébrale
SOLANA BEACH, Californie, 28 mars 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT) (la « Société »), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers le cerveau, annonce... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro gibt exklusive mehrjährige Lizenzvereinbarung mit UCSF für innovative intrazerebrale Zellverabreichungsplattform bekannt
SOLANA BEACH, Kalifornien, March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (das „Unternehmen“), ein weltweites Unternehmen für therapieermöglichende Plattformen, das die Navigation zum und die Verabreichung im Ge... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform
SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results
SOLANA BEACH, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue
SOLANA BEACH, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced preliminary, unaudi... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden
SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced enrollment of the f... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro to Present at Upcoming Investor Conferences
SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Reports Third Quarter 2022 Results
ClearPoint Neuro, Inc. Company Reaffirms 2022 Revenue Forecast SOLANA BEACH, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Reports Second Quarter 2022 Results
SOLANA BEACH, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results f... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro beglückwünscht Partner PTC Therapeutics für den Erhalt der Marktzulassung durch die Europäische Kommission für Upstaza™ - die erste krankheitsmodifizierende Behandlung von AADC-Mangel
Die erste zur direkten Infusion in das Gehirn zugelassene Gentherapie wird mit der SmartFlow® Neurokanüle von ClearPoint verabreicht SOLANA BEACH, Kalifornien, July 22, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (das... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency
SOLANA BEACH, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, congratulates partner PTC Therapeut... Full story
Yahoo Finance • 2 years ago
ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy
SOLANA BEACH, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain today congratulates partner Neurona... Full story
